|
While the vast majority of activities at Johns Hopkins Medicine operate
smoothly and bring extraordinarily positive attention, the increasing
complexity of those activities sometimes presents challenges that must
be addressed in a rigorous, and coordinated fashion. The Crisis Notification
Policy and Guidelines attached below were developed to assist faculty
and staff in meeting those occasional challenges. Your attention to
them, and cooperation, are appreciated.
Sincerely,
Edward D. Miller, M.D.
Dean of the Medical Faculty
CEO, Johns Hopkins Medicine |
Ronald R. Peterson
President
The Johns Hopkins Health System
The Johns Hopkins Hospital |
Policy and Rationale: Research, clinical, educational and administrative
operations of The Johns Hopkins Hospital and Health System, and The
Johns Hopkins University School of Medicine (collectively, JHM) are
the focus of intense and sometimes overlapping scrutiny and formal investigatory
and legal activity by governmental, regulatory, accrediting, law enforcement,
media and public interest offices and organizations. The targeted issues
and operations are frequently complex and may have the potential to
result in highly visible investigations, penalties, expenses and damage
to institutional reputation. Providing appropriate attention and resources
to all such activities, and reducing our vulnerabilities, require a
high level of coordinated risk assessment, risk management, corrective
actions, and communications to internal and external audiences and stakeholders.
To meet this requirement, JHM leadership and relevant experts must be
made aware as soon as possible of such activities and potential vulnerabilities.
Therefore, it is the policy of JHM to require all employees, including
faculty, directors, managers, house officers, and nurses to immediately
notify appropriate leadership if they receive or have information related
to such activities by outside organizations. The following guidelines
are intended to facilitate notification.
--Notification should be made immediately about actual or probable
activities including, but not limited to inquiries, investigations,
audits or formal reviews by legal, law enforcement, regulatory, accrediting,
and similar institutions and organizations.* (See examples below.)
--Notification can be oral or written, but should include all pertinent
documents and details. For example, if an employee receives a notice
from the U.S. Food and Drug Administration regarding a recall, the name
of the drug or device, along with its manufacturer, and any other relevant
dates or identifying information, should be provided.
--Notification should be directed to JHM Vice President and General
Counsel Joanne Pollak, BRB 102, 733 North Broadway, Baltimore, MD 21205
(410 614 3322, jpollak@jhmi.edu ), with a copy to JHU Vice President
and General Counsel Kumiki Gibson, Garland Hall #113, 3400 North Charles
Street, Baltimore, MD 21218 ( 410 516 8128, kgibson@jhu.edu),
as well as to your supervisors (e.g., department chairman, dean, division
head). It is the responsibility of the JHM General Counsel's office
to evaluate each notification, confidentially relay pertinent information
to a Core Crisis Management Group (CCMG) and, when necessary, to convene
members of the CCMG or other relevant experts to develop and implement
appropriate responses.
--The Core Crisis Management Group will be comprised of Edward D. Miller,
M.D., Dean/CEO, JHM; Ronald R. Peterson, President, The Johns Hopkins
Hospital and Health System; Richard Grossi, Chief Financial Officer,
JHM; Judy A. Reitz, Sc.D., Vice President for Quality Improvement, JHM
and Executive Vice President, The Johns Hopkins Hospital; Joanne E.
Pollak, Vice President and General Counsel, JHM; Kumiki Gibson, Vice
President and General Counsel, Johns Hopkins University; G. Daniel Shealer,
Vice President for Corporate Compliance, The Johns Hopkins Hospital
and Health System; Frederick Savage, JHU Deputy General Counsel; Joseph
Coppola, Vice President, Corporate Security, JHM; Elaine Freeman, Vice
President, Corporate Communications, JHM; Joann Rodgers, Deputy Director,
Corporate Communications and Director of Media Relations, JHM; and Christine
White, Assistant Dean, School of Medicine.
*Examples:
1. A department chair receives word from the Accreditation Council for
General Medical Education (ACGME) that a resident has threatened to
file a complaint charging a violation of rules governing residency hours.
2. A public information officer learns from a reporter that a Hopkins
patient claims he has been misdiagnosed and mistreated, and that the
patient's family is planning a press conference to announce a lawsuit
against Hopkins physicians and the Hospital.
3. A pulmonologist notices an unusual cluster of treatment-related infections
and deaths among patients in his clinic shortly after initiating a new
protocol and must consider reporting the cluster to health departments
and/or the U.S. Centers for Disease Control.
4. A clinic administrator receives a letter from a patient complaining
that her privacy has been invaded and that information about her medical
condition has been inappropriately divulged to a member of her family.
5. An administrator and a principal investigator receive a letter notifying
them that the federal Inspector General's office intends to audit financial
information related to a clinical trial.
6. A financial officer learns from an employee that a renewal application
for an NIH grant by a faculty member may contain fraudulent or incorrect
billing information.
7. A nurse learns that a regulatory agency has, without notice, sent
a team of inspectors to her clinical unit and is asking for certain
medical records.
8. An administrator receives a notice from a state agency stating that
a regulation has been violated and asking for a response within fifteen
(15) days.
9. A physician learns of a recall notice from a medical device manufacturer
to a purchasing agent that potentially raises questions about harm to
patients from prior use of the device.
10. A resident in the ER sees a healthy research volunteer who has recently
participated in a study and has completely unexpected and potentially
life threatening symptoms.
|